nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP3A4—bone cancer	0.694	1	CbGaD
Clomifene—Heart malformation—Cisplatin—bone cancer	0.0125	0.0817	CcSEcCtD
Clomifene—Heart disease congenital—Cisplatin—bone cancer	0.0102	0.0668	CcSEcCtD
Clomifene—Heart malformation—Epirubicin—bone cancer	0.00642	0.0419	CcSEcCtD
Clomifene—Heart malformation—Doxorubicin—bone cancer	0.00594	0.0388	CcSEcCtD
Clomifene—Heart disease congenital—Epirubicin—bone cancer	0.00525	0.0343	CcSEcCtD
Clomifene—Heart disease congenital—Doxorubicin—bone cancer	0.00486	0.0317	CcSEcCtD
Clomifene—Phlebitis—Carboplatin—bone cancer	0.00339	0.0221	CcSEcCtD
Clomifene—Leukaemia—Methotrexate—bone cancer	0.0024	0.0157	CcSEcCtD
Clomifene—Thromboembolic event—Methotrexate—bone cancer	0.0024	0.0157	CcSEcCtD
Clomifene—Leukaemia—Epirubicin—bone cancer	0.00225	0.0147	CcSEcCtD
Clomifene—Blindness—Cisplatin—bone cancer	0.00213	0.0139	CcSEcCtD
Clomifene—Leukaemia—Doxorubicin—bone cancer	0.00208	0.0136	CcSEcCtD
Clomifene—Optic neuritis—Cisplatin—bone cancer	0.00192	0.0125	CcSEcCtD
Clomifene—Erythema nodosum—Epirubicin—bone cancer	0.0014	0.00914	CcSEcCtD
Clomifene—Tenderness—Cisplatin—bone cancer	0.00135	0.00882	CcSEcCtD
Clomifene—Ascites—Epirubicin—bone cancer	0.00133	0.0087	CcSEcCtD
Clomifene—Erythema nodosum—Doxorubicin—bone cancer	0.0013	0.00846	CcSEcCtD
Clomifene—Ascites—Doxorubicin—bone cancer	0.00123	0.00805	CcSEcCtD
Clomifene—Pain—Carboplatin—bone cancer	0.00123	0.00801	CcSEcCtD
Clomifene—Hepatocellular injury—Cisplatin—bone cancer	0.00118	0.0077	CcSEcCtD
Clomifene—Ospemifene—CYP3A4—bone cancer	0.00116	0.394	CrCbGaD
Clomifene—Body temperature increased—Carboplatin—bone cancer	0.00113	0.0074	CcSEcCtD
Clomifene—Blindness—Epirubicin—bone cancer	0.00109	0.00714	CcSEcCtD
Clomifene—Blindness—Doxorubicin—bone cancer	0.00101	0.00661	CcSEcCtD
Clomifene—Embolism—Methotrexate—bone cancer	0.00101	0.00658	CcSEcCtD
Clomifene—Transaminases increased—Epirubicin—bone cancer	0.000995	0.0065	CcSEcCtD
Clomifene—Phlebitis—Cisplatin—bone cancer	0.000993	0.00649	CcSEcCtD
Clomifene—Optic neuritis—Epirubicin—bone cancer	0.000984	0.00643	CcSEcCtD
Clomifene—Cyst—Methotrexate—bone cancer	0.000968	0.00632	CcSEcCtD
Clomifene—Deafness—Cisplatin—bone cancer	0.000957	0.00625	CcSEcCtD
Clomifene—Liver disorder—Methotrexate—bone cancer	0.000949	0.0062	CcSEcCtD
Clomifene—Toremifene—CYP3A4—bone cancer	0.000943	0.321	CrCbGaD
Clomifene—Embolism—Epirubicin—bone cancer	0.000943	0.00616	CcSEcCtD
Clomifene—Transaminases increased—Doxorubicin—bone cancer	0.000921	0.00601	CcSEcCtD
Clomifene—Optic neuritis—Doxorubicin—bone cancer	0.000911	0.00595	CcSEcCtD
Clomifene—Cyst—Epirubicin—bone cancer	0.000906	0.00591	CcSEcCtD
Clomifene—Cerebrovascular accident—Cisplatin—bone cancer	0.000873	0.0057	CcSEcCtD
Clomifene—Embolism—Doxorubicin—bone cancer	0.000873	0.0057	CcSEcCtD
Clomifene—Thrombosis—Epirubicin—bone cancer	0.000855	0.00558	CcSEcCtD
Clomifene—Cyst—Doxorubicin—bone cancer	0.000838	0.00547	CcSEcCtD
Clomifene—Dermatitis atopic—Epirubicin—bone cancer	0.000818	0.00534	CcSEcCtD
Clomifene—Irritability—Cisplatin—bone cancer	0.000817	0.00533	CcSEcCtD
Clomifene—Scotoma—Epirubicin—bone cancer	0.000797	0.00521	CcSEcCtD
Clomifene—Thrombosis—Doxorubicin—bone cancer	0.000791	0.00517	CcSEcCtD
Clomifene—Dermatitis atopic—Doxorubicin—bone cancer	0.000757	0.00494	CcSEcCtD
Clomifene—Scotoma—Doxorubicin—bone cancer	0.000738	0.00482	CcSEcCtD
Clomifene—Pancreatitis—Cisplatin—bone cancer	0.000725	0.00473	CcSEcCtD
Clomifene—Abdominal discomfort—Cisplatin—bone cancer	0.000709	0.00463	CcSEcCtD
Clomifene—Renal failure—Cisplatin—bone cancer	0.000648	0.00423	CcSEcCtD
Clomifene—Pulmonary embolism—Methotrexate—bone cancer	0.000647	0.00422	CcSEcCtD
Clomifene—Hepatocellular injury—Epirubicin—bone cancer	0.000605	0.00395	CcSEcCtD
Clomifene—Pulmonary embolism—Epirubicin—bone cancer	0.000605	0.00395	CcSEcCtD
Clomifene—Neoplasm—Methotrexate—bone cancer	0.000585	0.00382	CcSEcCtD
Clomifene—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000577	0.00384	CbGpPWpGaD
Clomifene—CYP1A1—Estrogen Receptor Pathway—JUN—bone cancer	0.000573	0.00382	CbGpPWpGaD
Clomifene—Visual impairment—Cisplatin—bone cancer	0.00057	0.00373	CcSEcCtD
Clomifene—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000566	0.00378	CbGpPWpGaD
Clomifene—Pulmonary embolism—Doxorubicin—bone cancer	0.00056	0.00366	CcSEcCtD
Clomifene—Hepatocellular injury—Doxorubicin—bone cancer	0.00056	0.00366	CcSEcCtD
Clomifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00056	0.00373	CbGpPWpGaD
Clomifene—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000559	0.00373	CbGpPWpGaD
Clomifene—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000557	0.00371	CbGpPWpGaD
Clomifene—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000554	0.00369	CbGpPWpGaD
Clomifene—Tinnitus—Cisplatin—bone cancer	0.000552	0.0036	CcSEcCtD
Clomifene—Flushing—Cisplatin—bone cancer	0.000549	0.00359	CcSEcCtD
Clomifene—ESR1—Estrogen signaling pathway—JUN—bone cancer	0.000548	0.00365	CbGpPWpGaD
Clomifene—Neoplasm—Epirubicin—bone cancer	0.000547	0.00357	CcSEcCtD
Clomifene—Thrombophlebitis—Methotrexate—bone cancer	0.000542	0.00354	CcSEcCtD
Clomifene—EBP—Metabolism—NT5C3A—bone cancer	0.000531	0.00354	CbGpPWpGaD
Clomifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000531	0.00354	CbGpPWpGaD
Clomifene—Arrhythmia—Cisplatin—bone cancer	0.000529	0.00345	CcSEcCtD
Clomifene—Mental disability—Epirubicin—bone cancer	0.000525	0.00343	CcSEcCtD
Clomifene—ESR1—FOXM1 transcription factor network—CDK4—bone cancer	0.000525	0.0035	CbGpPWpGaD
Clomifene—Alopecia—Cisplatin—bone cancer	0.000523	0.00342	CcSEcCtD
Clomifene—CYP1A1—Tryptophan metabolism—CYP3A4—bone cancer	0.000522	0.00348	CbGpPWpGaD
Clomifene—Erythema—Cisplatin—bone cancer	0.000515	0.00337	CcSEcCtD
Clomifene—Phlebitis—Epirubicin—bone cancer	0.00051	0.00333	CcSEcCtD
Clomifene—Flatulence—Cisplatin—bone cancer	0.000508	0.00332	CcSEcCtD
Clomifene—Thrombophlebitis—Epirubicin—bone cancer	0.000508	0.00331	CcSEcCtD
Clomifene—Neoplasm—Doxorubicin—bone cancer	0.000506	0.00331	CcSEcCtD
Clomifene—Visual disturbance—Methotrexate—bone cancer	0.000496	0.00324	CcSEcCtD
Clomifene—Eye pain—Epirubicin—bone cancer	0.000487	0.00318	CcSEcCtD
Clomifene—Mental disability—Doxorubicin—bone cancer	0.000486	0.00317	CcSEcCtD
Clomifene—Vision blurred—Cisplatin—bone cancer	0.000486	0.00317	CcSEcCtD
Clomifene—Cerebrovascular accident—Methotrexate—bone cancer	0.000479	0.00313	CcSEcCtD
Clomifene—Phlebitis—Doxorubicin—bone cancer	0.000472	0.00308	CcSEcCtD
Clomifene—Hot flush—Epirubicin—bone cancer	0.00047	0.00307	CcSEcCtD
Clomifene—Thrombophlebitis—Doxorubicin—bone cancer	0.00047	0.00307	CcSEcCtD
Clomifene—Increased appetite—Epirubicin—bone cancer	0.000468	0.00305	CcSEcCtD
Clomifene—Menopausal symptoms—Epirubicin—bone cancer	0.000466	0.00304	CcSEcCtD
Clomifene—CYP11A1—Biological oxidations—CYP3A4—bone cancer	0.000463	0.00308	CbGpPWpGaD
Clomifene—Phenoxybenzamine—CYP3A4—bone cancer	0.000461	0.157	CrCbGaD
Clomifene—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000459	0.00306	CbGpPWpGaD
Clomifene—ESR1—FOXM1 transcription factor network—RB1—bone cancer	0.000457	0.00304	CbGpPWpGaD
Clomifene—CYP11A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000456	0.00304	CbGpPWpGaD
Clomifene—Eye pain—Doxorubicin—bone cancer	0.00045	0.00294	CcSEcCtD
Clomifene—Cerebrovascular accident—Epirubicin—bone cancer	0.000448	0.00293	CcSEcCtD
Clomifene—Irritability—Methotrexate—bone cancer	0.000448	0.00293	CcSEcCtD
Clomifene—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000448	0.00298	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.000447	0.00298	CbGpPWpGaD
Clomifene—Convulsion—Cisplatin—bone cancer	0.000446	0.00292	CcSEcCtD
Clomifene—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000446	0.00297	CbGpPWpGaD
Clomifene—Mood swings—Methotrexate—bone cancer	0.000445	0.0029	CcSEcCtD
Clomifene—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000442	0.00294	CbGpPWpGaD
Clomifene—Diplopia—Epirubicin—bone cancer	0.000439	0.00287	CcSEcCtD
Clomifene—Myalgia—Cisplatin—bone cancer	0.000439	0.00286	CcSEcCtD
Clomifene—ESR1—FOXM1 transcription factor network—MMP2—bone cancer	0.000438	0.00292	CbGpPWpGaD
Clomifene—Anxiety—Cisplatin—bone cancer	0.000437	0.00285	CcSEcCtD
Clomifene—Hot flush—Doxorubicin—bone cancer	0.000435	0.00284	CcSEcCtD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.000434	0.0029	CbGpPWpGaD
Clomifene—Increased appetite—Doxorubicin—bone cancer	0.000433	0.00283	CcSEcCtD
Clomifene—Affect lability—Epirubicin—bone cancer	0.000433	0.00282	CcSEcCtD
Clomifene—Migraine—Epirubicin—bone cancer	0.000433	0.00282	CcSEcCtD
Clomifene—Menopausal symptoms—Doxorubicin—bone cancer	0.000431	0.00281	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000425	0.00283	CbGpPWpGaD
Clomifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000424	0.00283	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—PLAU—bone cancer	0.000423	0.00282	CbGpPWpGaD
Clomifene—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000422	0.00281	CbGpPWpGaD
Clomifene—Oedema—Cisplatin—bone cancer	0.000421	0.00275	CcSEcCtD
Clomifene—CYP11A1—Corticotropin-releasing hormone—BRAF—bone cancer	0.000419	0.00279	CbGpPWpGaD
Clomifene—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000416	0.00278	CbGpPWpGaD
Clomifene—Mood swings—Epirubicin—bone cancer	0.000416	0.00272	CcSEcCtD
Clomifene—Cerebrovascular accident—Doxorubicin—bone cancer	0.000415	0.00271	CcSEcCtD
Clomifene—Tachycardia—Cisplatin—bone cancer	0.00041	0.00268	CcSEcCtD
Clomifene—Diplopia—Doxorubicin—bone cancer	0.000407	0.00266	CcSEcCtD
Clomifene—CYP19A1—Tryptophan metabolism—MDM2—bone cancer	0.000404	0.0027	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—CDK4—bone cancer	0.0004	0.00267	CbGpPWpGaD
Clomifene—Migraine—Doxorubicin—bone cancer	0.0004	0.00261	CcSEcCtD
Clomifene—Affect lability—Doxorubicin—bone cancer	0.0004	0.00261	CcSEcCtD
Clomifene—Pancreatitis—Methotrexate—bone cancer	0.000398	0.0026	CcSEcCtD
Clomifene—CYP11A1—Biological oxidations—GSTP1—bone cancer	0.000396	0.00264	CbGpPWpGaD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000392	0.00261	CbGpPWpGaD
Clomifene—CYP11A1—Metapathway biotransformation—GSTP1—bone cancer	0.00039	0.0026	CbGpPWpGaD
Clomifene—Abdominal discomfort—Methotrexate—bone cancer	0.000389	0.00254	CcSEcCtD
Clomifene—Mood swings—Doxorubicin—bone cancer	0.000385	0.00252	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000383	0.0025	CcSEcCtD
Clomifene—Abdominal distension—Epirubicin—bone cancer	0.000382	0.0025	CcSEcCtD
Clomifene—Paraesthesia—Cisplatin—bone cancer	0.000378	0.00247	CcSEcCtD
Clomifene—Tamoxifen—CYP3A4—bone cancer	0.000377	0.128	CrCbGaD
Clomifene—Dyspnoea—Cisplatin—bone cancer	0.000375	0.00245	CcSEcCtD
Clomifene—Pancreatitis—Epirubicin—bone cancer	0.000372	0.00243	CcSEcCtD
Clomifene—ESR1—AP-1 transcription factor network—PLAU—bone cancer	0.000369	0.00246	CbGpPWpGaD
Clomifene—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000365	0.00244	CbGpPWpGaD
Clomifene—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000363	0.00242	CbGpPWpGaD
Clomifene—Pain—Cisplatin—bone cancer	0.00036	0.00235	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000358	0.00238	CbGpPWpGaD
Clomifene—Renal failure—Methotrexate—bone cancer	0.000356	0.00232	CcSEcCtD
Clomifene—Abdominal distension—Doxorubicin—bone cancer	0.000354	0.00231	CcSEcCtD
Clomifene—Pollakiuria—Epirubicin—bone cancer	0.000351	0.00229	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000349	0.00233	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000349	0.00232	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—RB1—bone cancer	0.000348	0.00232	CbGpPWpGaD
Clomifene—Weight increased—Epirubicin—bone cancer	0.000346	0.00226	CcSEcCtD
Clomifene—Pancreatitis—Doxorubicin—bone cancer	0.000345	0.00225	CcSEcCtD
Clomifene—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000342	0.00228	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.000336	0.00224	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000335	0.00224	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	0.000334	0.00223	CbGpPWpGaD
Clomifene—Renal failure—Epirubicin—bone cancer	0.000333	0.00217	CcSEcCtD
Clomifene—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000333	0.00222	CbGpPWpGaD
Clomifene—Body temperature increased—Cisplatin—bone cancer	0.000332	0.00217	CcSEcCtD
Clomifene—Jaundice—Epirubicin—bone cancer	0.00033	0.00216	CcSEcCtD
Clomifene—ESR1—FOXA1 transcription factor network—JUN—bone cancer	0.000326	0.00217	CbGpPWpGaD
Clomifene—Hepatitis—Methotrexate—bone cancer	0.000325	0.00212	CcSEcCtD
Clomifene—Pollakiuria—Doxorubicin—bone cancer	0.000325	0.00212	CcSEcCtD
Clomifene—Weight increased—Doxorubicin—bone cancer	0.00032	0.00209	CcSEcCtD
Clomifene—Visual impairment—Methotrexate—bone cancer	0.000313	0.00204	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000312	0.00208	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000311	0.00207	CbGpPWpGaD
Clomifene—Hypersensitivity—Cisplatin—bone cancer	0.00031	0.00202	CcSEcCtD
Clomifene—Renal failure—Doxorubicin—bone cancer	0.000308	0.00201	CcSEcCtD
Clomifene—Erythema multiforme—Methotrexate—bone cancer	0.000307	0.00201	CcSEcCtD
Clomifene—CYP19A1—Biological oxidations—CYP3A4—bone cancer	0.000306	0.00204	CbGpPWpGaD
Clomifene—Jaundice—Doxorubicin—bone cancer	0.000305	0.00199	CcSEcCtD
Clomifene—ESR1—Gene Expression—ZNF77—bone cancer	0.000305	0.00203	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000304	0.00203	CbGpPWpGaD
Clomifene—Hepatitis—Epirubicin—bone cancer	0.000304	0.00199	CcSEcCtD
Clomifene—Tinnitus—Methotrexate—bone cancer	0.000303	0.00198	CcSEcCtD
Clomifene—CYP19A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000302	0.00201	CbGpPWpGaD
Clomifene—Asthenia—Cisplatin—bone cancer	0.000302	0.00197	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.0003	0.002	CbGpPWpGaD
Clomifene—Visual impairment—Epirubicin—bone cancer	0.000293	0.00191	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000291	0.00194	CbGpPWpGaD
Clomifene—Diarrhoea—Cisplatin—bone cancer	0.000288	0.00188	CcSEcCtD
Clomifene—Erythema multiforme—Epirubicin—bone cancer	0.000287	0.00188	CcSEcCtD
Clomifene—Alopecia—Methotrexate—bone cancer	0.000287	0.00187	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000284	0.00189	CbGpPWpGaD
Clomifene—Tinnitus—Epirubicin—bone cancer	0.000283	0.00185	CcSEcCtD
Clomifene—Erythema—Methotrexate—bone cancer	0.000283	0.00185	CcSEcCtD
Clomifene—Flushing—Epirubicin—bone cancer	0.000282	0.00184	CcSEcCtD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000281	0.00188	CbGpPWpGaD
Clomifene—Hepatitis—Doxorubicin—bone cancer	0.000281	0.00184	CcSEcCtD
Clomifene—CYP11A1—Metabolism—NDUFA12—bone cancer	0.000277	0.00185	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000277	0.00185	CbGpPWpGaD
Clomifene—Back pain—Methotrexate—bone cancer	0.000274	0.00179	CcSEcCtD
Clomifene—Arrhythmia—Epirubicin—bone cancer	0.000272	0.00177	CcSEcCtD
Clomifene—Visual impairment—Doxorubicin—bone cancer	0.000271	0.00177	CcSEcCtD
Clomifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000269	0.00179	CbGpPWpGaD
Clomifene—Alopecia—Epirubicin—bone cancer	0.000269	0.00175	CcSEcCtD
Clomifene—Vomiting—Cisplatin—bone cancer	0.000267	0.00175	CcSEcCtD
Clomifene—Vision blurred—Methotrexate—bone cancer	0.000267	0.00174	CcSEcCtD
Clomifene—Erythema multiforme—Doxorubicin—bone cancer	0.000266	0.00174	CcSEcCtD
Clomifene—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000266	0.00177	CbGpPWpGaD
Clomifene—Rash—Cisplatin—bone cancer	0.000265	0.00173	CcSEcCtD
Clomifene—Dermatitis—Cisplatin—bone cancer	0.000265	0.00173	CcSEcCtD
Clomifene—Erythema—Epirubicin—bone cancer	0.000265	0.00173	CcSEcCtD
Clomifene—Tinnitus—Doxorubicin—bone cancer	0.000262	0.00171	CcSEcCtD
Clomifene—CYP19A1—Biological oxidations—GSTP1—bone cancer	0.000262	0.00175	CbGpPWpGaD
Clomifene—Flushing—Doxorubicin—bone cancer	0.000261	0.0017	CcSEcCtD
Clomifene—Flatulence—Epirubicin—bone cancer	0.000261	0.0017	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.00026	0.00174	CbGpPWpGaD
Clomifene—Tension—Epirubicin—bone cancer	0.00026	0.0017	CcSEcCtD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000259	0.00172	CbGpPWpGaD
Clomifene—CYP19A1—Metapathway biotransformation—GSTP1—bone cancer	0.000258	0.00172	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—JUN—bone cancer	0.000258	0.00172	CbGpPWpGaD
Clomifene—Nervousness—Epirubicin—bone cancer	0.000257	0.00168	CcSEcCtD
Clomifene—Back pain—Epirubicin—bone cancer	0.000256	0.00167	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000254	0.0017	CbGpPWpGaD
Clomifene—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000254	0.0017	CbGpPWpGaD
Clomifene—Vertigo—Methotrexate—bone cancer	0.000254	0.00166	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000252	0.00168	CbGpPWpGaD
Clomifene—Arrhythmia—Doxorubicin—bone cancer	0.000251	0.00164	CcSEcCtD
Clomifene—Nausea—Cisplatin—bone cancer	0.00025	0.00163	CcSEcCtD
Clomifene—Vision blurred—Epirubicin—bone cancer	0.000249	0.00163	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000249	0.00166	CbGpPWpGaD
Clomifene—Alopecia—Doxorubicin—bone cancer	0.000249	0.00162	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000247	0.00165	CbGpPWpGaD
Clomifene—Convulsion—Methotrexate—bone cancer	0.000245	0.0016	CcSEcCtD
Clomifene—Erythema—Doxorubicin—bone cancer	0.000245	0.0016	CcSEcCtD
Clomifene—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000244	0.00163	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000242	0.00161	CbGpPWpGaD
Clomifene—Flatulence—Doxorubicin—bone cancer	0.000241	0.00158	CcSEcCtD
Clomifene—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000241	0.00161	CbGpPWpGaD
Clomifene—Chest pain—Methotrexate—bone cancer	0.000241	0.00157	CcSEcCtD
Clomifene—Arthralgia—Methotrexate—bone cancer	0.000241	0.00157	CcSEcCtD
Clomifene—Myalgia—Methotrexate—bone cancer	0.000241	0.00157	CcSEcCtD
Clomifene—Tension—Doxorubicin—bone cancer	0.00024	0.00157	CcSEcCtD
Clomifene—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.00024	0.0016	CbGpPWpGaD
Clomifene—Nervousness—Doxorubicin—bone cancer	0.000238	0.00155	CcSEcCtD
Clomifene—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000238	0.00159	CbGpPWpGaD
Clomifene—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000238	0.00159	CbGpPWpGaD
Clomifene—Vertigo—Epirubicin—bone cancer	0.000238	0.00155	CcSEcCtD
Clomifene—Syncope—Epirubicin—bone cancer	0.000237	0.00155	CcSEcCtD
Clomifene—Back pain—Doxorubicin—bone cancer	0.000237	0.00155	CcSEcCtD
Clomifene—Palpitations—Epirubicin—bone cancer	0.000234	0.00153	CcSEcCtD
Clomifene—EBP—Metabolism—ENO2—bone cancer	0.000233	0.00155	CbGpPWpGaD
Clomifene—Loss of consciousness—Epirubicin—bone cancer	0.000233	0.00152	CcSEcCtD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000231	0.00154	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000231	0.00154	CbGpPWpGaD
Clomifene—Vision blurred—Doxorubicin—bone cancer	0.000231	0.00151	CcSEcCtD
Clomifene—ESR1—Regulation of Telomerase—JUN—bone cancer	0.00023	0.00153	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—NT5C3A—bone cancer	0.00023	0.00153	CbGpPWpGaD
Clomifene—Convulsion—Epirubicin—bone cancer	0.000229	0.0015	CcSEcCtD
Clomifene—Hypertension—Epirubicin—bone cancer	0.000228	0.00149	CcSEcCtD
Clomifene—Arthralgia—Epirubicin—bone cancer	0.000225	0.00147	CcSEcCtD
Clomifene—Chest pain—Epirubicin—bone cancer	0.000225	0.00147	CcSEcCtD
Clomifene—Myalgia—Epirubicin—bone cancer	0.000225	0.00147	CcSEcCtD
Clomifene—ESR1—AP-1 transcription factor network—JUN—bone cancer	0.000225	0.0015	CbGpPWpGaD
Clomifene—Anxiety—Epirubicin—bone cancer	0.000225	0.00147	CcSEcCtD
Clomifene—Vertigo—Doxorubicin—bone cancer	0.00022	0.00144	CcSEcCtD
Clomifene—Syncope—Doxorubicin—bone cancer	0.00022	0.00143	CcSEcCtD
Clomifene—ESR1—LKB1 signaling events—TP53—bone cancer	0.000219	0.00146	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—MMP9—bone cancer	0.000219	0.00146	CbGpPWpGaD
Clomifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000218	0.00145	CbGpPWpGaD
Clomifene—Palpitations—Doxorubicin—bone cancer	0.000216	0.00141	CcSEcCtD
Clomifene—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000216	0.00144	CbGpPWpGaD
Clomifene—Oedema—Epirubicin—bone cancer	0.000216	0.00141	CcSEcCtD
Clomifene—EBP—Metabolism—DHFR—bone cancer	0.000216	0.00144	CbGpPWpGaD
Clomifene—Loss of consciousness—Doxorubicin—bone cancer	0.000215	0.00141	CcSEcCtD
Clomifene—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	0.000214	0.00143	CbGpPWpGaD
Clomifene—Shock—Epirubicin—bone cancer	0.000212	0.00139	CcSEcCtD
Clomifene—Convulsion—Doxorubicin—bone cancer	0.000212	0.00139	CcSEcCtD
Clomifene—Hypertension—Doxorubicin—bone cancer	0.000211	0.00138	CcSEcCtD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000211	0.00141	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000211	0.00141	CbGpPWpGaD
Clomifene—Tachycardia—Epirubicin—bone cancer	0.000211	0.00138	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00021	0.00137	CcSEcCtD
Clomifene—Insomnia—Methotrexate—bone cancer	0.000209	0.00136	CcSEcCtD
Clomifene—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000209	0.00139	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000208	0.00139	CbGpPWpGaD
Clomifene—Myalgia—Doxorubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Clomifene—Chest pain—Doxorubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Clomifene—Arthralgia—Doxorubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Clomifene—Anxiety—Doxorubicin—bone cancer	0.000208	0.00136	CcSEcCtD
Clomifene—Paraesthesia—Methotrexate—bone cancer	0.000207	0.00135	CcSEcCtD
Clomifene—Dyspnoea—Methotrexate—bone cancer	0.000206	0.00134	CcSEcCtD
Clomifene—EBP—Metabolism—GNA11—bone cancer	0.000202	0.00134	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.0002	0.00133	CbGpPWpGaD
Clomifene—Oedema—Doxorubicin—bone cancer	0.0002	0.0013	CcSEcCtD
Clomifene—Fatigue—Methotrexate—bone cancer	0.000199	0.0013	CcSEcCtD
Clomifene—Pain—Methotrexate—bone cancer	0.000197	0.00129	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000197	0.00128	CcSEcCtD
Clomifene—Shock—Doxorubicin—bone cancer	0.000197	0.00128	CcSEcCtD
Clomifene—Insomnia—Epirubicin—bone cancer	0.000195	0.00128	CcSEcCtD
Clomifene—Tachycardia—Doxorubicin—bone cancer	0.000195	0.00127	CcSEcCtD
Clomifene—Paraesthesia—Epirubicin—bone cancer	0.000194	0.00127	CcSEcCtD
Clomifene—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000193	0.00128	CbGpPWpGaD
Clomifene—Dyspnoea—Epirubicin—bone cancer	0.000193	0.00126	CcSEcCtD
Clomifene—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.00019	0.00127	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000189	0.00126	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000189	0.00126	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000187	0.00124	CbGpPWpGaD
Clomifene—Fatigue—Epirubicin—bone cancer	0.000186	0.00122	CcSEcCtD
Clomifene—Constipation—Epirubicin—bone cancer	0.000185	0.00121	CcSEcCtD
Clomifene—Pain—Epirubicin—bone cancer	0.000185	0.00121	CcSEcCtD
Clomifene—KCNH2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000184	0.00123	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—NDUFA12—bone cancer	0.000184	0.00122	CbGpPWpGaD
Clomifene—Urticaria—Methotrexate—bone cancer	0.000183	0.0012	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000183	0.00122	CbGpPWpGaD
Clomifene—EBP—Metabolism—CYP3A4—bone cancer	0.000183	0.00122	CbGpPWpGaD
Clomifene—Body temperature increased—Methotrexate—bone cancer	0.000182	0.00119	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000182	0.00119	CcSEcCtD
Clomifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000182	0.00121	CbGpPWpGaD
Clomifene—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000182	0.00121	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—EGFR—bone cancer	0.000181	0.00121	CbGpPWpGaD
Clomifene—Insomnia—Doxorubicin—bone cancer	0.000181	0.00118	CcSEcCtD
Clomifene—Paraesthesia—Doxorubicin—bone cancer	0.000179	0.00117	CcSEcCtD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000179	0.0012	CbGpPWpGaD
Clomifene—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000179	0.00119	CbGpPWpGaD
Clomifene—Dyspnoea—Doxorubicin—bone cancer	0.000178	0.00116	CcSEcCtD
Clomifene—ESR1—Signaling by ERBB4—KIT—bone cancer	0.000177	0.00118	CbGpPWpGaD
Clomifene—Fatigue—Doxorubicin—bone cancer	0.000172	0.00113	CcSEcCtD
Clomifene—Urticaria—Epirubicin—bone cancer	0.000172	0.00112	CcSEcCtD
Clomifene—Pain—Doxorubicin—bone cancer	0.000171	0.00112	CcSEcCtD
Clomifene—Constipation—Doxorubicin—bone cancer	0.000171	0.00112	CcSEcCtD
Clomifene—Body temperature increased—Epirubicin—bone cancer	0.000171	0.00111	CcSEcCtD
Clomifene—Hypersensitivity—Methotrexate—bone cancer	0.00017	0.00111	CcSEcCtD
Clomifene—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000169	0.00113	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000167	0.00111	CbGpPWpGaD
Clomifene—Asthenia—Methotrexate—bone cancer	0.000166	0.00108	CcSEcCtD
Clomifene—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000165	0.0011	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000164	0.00109	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000164	0.00109	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000164	0.00109	CbGpPWpGaD
Clomifene—Pruritus—Methotrexate—bone cancer	0.000163	0.00107	CcSEcCtD
Clomifene—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000163	0.00108	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000161	0.00107	CbGpPWpGaD
Clomifene—Hypersensitivity—Epirubicin—bone cancer	0.000159	0.00104	CcSEcCtD
Clomifene—Urticaria—Doxorubicin—bone cancer	0.000159	0.00104	CcSEcCtD
Clomifene—KCNH2—Neuronal System—BRAF—bone cancer	0.000159	0.00106	CbGpPWpGaD
Clomifene—Body temperature increased—Doxorubicin—bone cancer	0.000158	0.00103	CcSEcCtD
Clomifene—Diarrhoea—Methotrexate—bone cancer	0.000158	0.00103	CcSEcCtD
Clomifene—EBP—Metabolism—GSTP1—bone cancer	0.000156	0.00104	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000156	0.00104	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000156	0.00104	CbGpPWpGaD
Clomifene—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.000155	0.00104	CbGpPWpGaD
Clomifene—Asthenia—Epirubicin—bone cancer	0.000155	0.00101	CcSEcCtD
Clomifene—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000153	0.00102	CbGpPWpGaD
Clomifene—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000153	0.00102	CbGpPWpGaD
Clomifene—Pruritus—Epirubicin—bone cancer	0.000153	0.000998	CcSEcCtD
Clomifene—Dizziness—Methotrexate—bone cancer	0.000153	0.000997	CcSEcCtD
Clomifene—CYP19A1—Metabolism—NT5C3A—bone cancer	0.000152	0.00101	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—FUS—bone cancer	0.000149	0.000993	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—TP53—bone cancer	0.000148	0.00099	CbGpPWpGaD
Clomifene—Diarrhoea—Epirubicin—bone cancer	0.000148	0.000965	CcSEcCtD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000147	0.000983	CbGpPWpGaD
Clomifene—Hypersensitivity—Doxorubicin—bone cancer	0.000147	0.000961	CcSEcCtD
Clomifene—Vomiting—Methotrexate—bone cancer	0.000147	0.000958	CcSEcCtD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000147	0.000977	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000146	0.000974	CbGpPWpGaD
Clomifene—Rash—Methotrexate—bone cancer	0.000146	0.00095	CcSEcCtD
Clomifene—Dermatitis—Methotrexate—bone cancer	0.000145	0.000949	CcSEcCtD
Clomifene—Headache—Methotrexate—bone cancer	0.000145	0.000944	CcSEcCtD
Clomifene—Asthenia—Doxorubicin—bone cancer	0.000143	0.000936	CcSEcCtD
Clomifene—Dizziness—Epirubicin—bone cancer	0.000143	0.000933	CcSEcCtD
Clomifene—Pruritus—Doxorubicin—bone cancer	0.000141	0.000923	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.00014	0.000933	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—MDM2—bone cancer	0.000139	0.000928	CbGpPWpGaD
Clomifene—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000138	0.000919	CbGpPWpGaD
Clomifene—Vomiting—Epirubicin—bone cancer	0.000137	0.000897	CcSEcCtD
Clomifene—Nausea—Methotrexate—bone cancer	0.000137	0.000895	CcSEcCtD
Clomifene—Diarrhoea—Doxorubicin—bone cancer	0.000137	0.000893	CcSEcCtD
Clomifene—Rash—Epirubicin—bone cancer	0.000136	0.000889	CcSEcCtD
Clomifene—Dermatitis—Epirubicin—bone cancer	0.000136	0.000888	CcSEcCtD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000136	0.000906	CbGpPWpGaD
Clomifene—Headache—Epirubicin—bone cancer	0.000135	0.000884	CcSEcCtD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000133	0.00089	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000133	0.000886	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—MDM2—bone cancer	0.000133	0.000886	CbGpPWpGaD
Clomifene—Dizziness—Doxorubicin—bone cancer	0.000132	0.000863	CcSEcCtD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000132	0.000878	CbGpPWpGaD
Clomifene—Nausea—Epirubicin—bone cancer	0.000128	0.000838	CcSEcCtD
Clomifene—Vomiting—Doxorubicin—bone cancer	0.000127	0.00083	CcSEcCtD
Clomifene—Rash—Doxorubicin—bone cancer	0.000126	0.000823	CcSEcCtD
Clomifene—Dermatitis—Doxorubicin—bone cancer	0.000126	0.000822	CcSEcCtD
Clomifene—Headache—Doxorubicin—bone cancer	0.000125	0.000818	CcSEcCtD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000125	0.000832	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000122	0.000811	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—NT5C3A—bone cancer	0.000121	0.000807	CbGpPWpGaD
Clomifene—Nausea—Doxorubicin—bone cancer	0.000119	0.000775	CcSEcCtD
Clomifene—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000118	0.000787	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000116	0.000773	CbGpPWpGaD
Clomifene—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000116	0.000772	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000116	0.00077	CbGpPWpGaD
Clomifene—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000114	0.000762	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000112	0.000745	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000112	0.000744	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000111	0.000742	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—NDUFA12—bone cancer	0.000109	0.000726	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000107	0.000712	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000105	0.000697	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000105	0.000697	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—NR1I2—bone cancer	0.000103	0.000688	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000101	0.000672	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ENO2—bone cancer	0.000101	0.000671	CbGpPWpGaD
Clomifene—CYP1A2—Biological oxidations—GSTP1—bone cancer	9.91e-05	0.000661	CbGpPWpGaD
Clomifene—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	9.77e-05	0.000651	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.6e-05	0.00064	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—NT5C3A—bone cancer	9.57e-05	0.000638	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	9.56e-05	0.000637	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—EGFR—bone cancer	9.51e-05	0.000634	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—DHFR—bone cancer	9.34e-05	0.000622	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—NT5C3A—bone cancer	9.02e-05	0.000602	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	8.97e-05	0.000598	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—GNA11—bone cancer	8.72e-05	0.000582	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—NDUFA12—bone cancer	8.7e-05	0.00058	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	8.27e-05	0.000552	CbGpPWpGaD
Clomifene—EBP—Metabolism—PTGS2—bone cancer	8.1e-05	0.00054	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	8.03e-05	0.000535	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	7.92e-05	0.000528	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CYP3A4—bone cancer	7.91e-05	0.000527	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.87e-05	0.000525	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GRM4—bone cancer	7.74e-05	0.000516	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RGS1—bone cancer	7.74e-05	0.000516	CbGpPWpGaD
Clomifene—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.65e-05	0.00051	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—EIF2S1—bone cancer	7.63e-05	0.000508	CbGpPWpGaD
Clomifene—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.54e-05	0.000503	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—NT5C3A—bone cancer	7.21e-05	0.000481	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NDUFA12—bone cancer	6.94e-05	0.000463	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—GSTP1—bone cancer	6.77e-05	0.000451	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GRM1—bone cancer	6.71e-05	0.000448	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ENO2—bone cancer	6.67e-05	0.000444	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	6.65e-05	0.000443	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—EZH2—bone cancer	6.62e-05	0.000442	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—DHFR—bone cancer	6.18e-05	0.000412	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.13e-05	0.000409	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.91e-05	0.000394	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—GNA11—bone cancer	5.78e-05	0.000385	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—NT5C3A—bone cancer	5.75e-05	0.000384	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NDUFA12—bone cancer	5.36e-05	0.000357	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.33e-05	0.000355	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ENO2—bone cancer	5.31e-05	0.000354	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CYP3A4—bone cancer	5.24e-05	0.000349	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.21e-05	0.000348	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—DHFR—bone cancer	4.92e-05	0.000328	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SMO—bone cancer	4.73e-05	0.000315	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GNA11—bone cancer	4.6e-05	0.000307	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—GSTP1—bone cancer	4.48e-05	0.000299	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—NT5C3A—bone cancer	4.44e-05	0.000296	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—GNA11—bone cancer	4.33e-05	0.000288	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ENO2—bone cancer	4.19e-05	0.000279	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.19e-05	0.000279	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CYP3A4—bone cancer	4.17e-05	0.000278	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ATF1—bone cancer	4.02e-05	0.000268	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ENO2—bone cancer	3.95e-05	0.000264	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL3—bone cancer	3.92e-05	0.000261	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—DHFR—bone cancer	3.89e-05	0.000259	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—DHFR—bone cancer	3.67e-05	0.000244	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GNA11—bone cancer	3.64e-05	0.000242	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GSTP1—bone cancer	3.57e-05	0.000238	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.52e-05	0.000235	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PTGS2—bone cancer	3.5e-05	0.000234	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GNA11—bone cancer	3.43e-05	0.000228	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TGFBR2—bone cancer	3.35e-05	0.000224	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CYP3A4—bone cancer	3.3e-05	0.00022	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ENO2—bone cancer	3.16e-05	0.00021	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IGF1R—bone cancer	3.16e-05	0.00021	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CYP3A4—bone cancer	3.11e-05	0.000207	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.09e-05	0.000206	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—DHFR—bone cancer	2.93e-05	0.000195	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GSTP1—bone cancer	2.82e-05	0.000188	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GNA11—bone cancer	2.74e-05	0.000182	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GSTP1—bone cancer	2.66e-05	0.000177	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ENO2—bone cancer	2.52e-05	0.000168	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CYP3A4—bone cancer	2.48e-05	0.000165	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—DHFR—bone cancer	2.34e-05	0.000156	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PTGS2—bone cancer	2.32e-05	0.000155	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KIT—bone cancer	2.29e-05	0.000153	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GNA11—bone cancer	2.19e-05	0.000146	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—BRAF—bone cancer	2.15e-05	0.000143	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GSTP1—bone cancer	2.12e-05	0.000141	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000132	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.97e-05	0.000131	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ENO2—bone cancer	1.95e-05	0.00013	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PTGS2—bone cancer	1.85e-05	0.000123	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—DHFR—bone cancer	1.8e-05	0.00012	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MDM2—bone cancer	1.8e-05	0.00012	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GSTP1—bone cancer	1.69e-05	0.000113	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GNA11—bone cancer	1.69e-05	0.000112	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—JUN—bone cancer	1.57e-05	0.000104	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MMP9—bone cancer	1.52e-05	0.000102	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PTGS2—bone cancer	1.46e-05	9.73e-05	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PTGS2—bone cancer	1.38e-05	9.18e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GSTP1—bone cancer	1.31e-05	8.72e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—bone cancer	1.23e-05	8.21e-05	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PTGS2—bone cancer	1.1e-05	7.33e-05	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—bone cancer	1.03e-05	6.9e-05	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PTGS2—bone cancer	8.78e-06	5.85e-05	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PTGS2—bone cancer	6.78e-06	4.52e-05	CbGpPWpGaD
